However, overexpression of MXD3 was associated with shorter survival of prostate adenocarcinoma (PRAD), mesothelioma (MESO), LGG, KICH, uveal melanoma (UVM), lung adenocarcinoma (LUAD), KIRC, ACC, THYM, HNSC, LICH, and glioblastoma multiforme (GBM) (Fig. 3D). This evidence concerns the gene MXD3 and thymoma.